By The Registry Staff A clinical stage vaccine company is expanding its footprint in the Bay Area. Vaxcyte Inc., known for its efforts to combat pneumococcal diseases, has secured an additional 36,000 square feet of office and research space in its San Carlos headquarters building, according to a report from the Silicon Valley Business Journal. […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.
Signup for news and special announcements!
You have successfully joined our subscriber list.
CBRE's third-quarter data puts a 99,000-square-foot lease at 1960 Mandela Parkway on...
ByThe RegistryNovember 15, 2026Optical I/O chiplet maker Ayar Labs has taken nearly 93,000 square feet...
ByThe RegistryNovember 15, 2026Guidewire Software has signed a 78,911-square-foot direct lease with Franklin Templeton for...
ByThe RegistryNovember 15, 2026The San Francisco Board of Supervisors has approved lease amendments that let...
ByThe RegistryNovember 15, 2026